Business Context and Reporting Period
Company: Gossamer Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 3, 2026
Reporting Period: Single event date (September 3, 2026)
This filing reports a corporate governance action taken by the Board of Directors regarding the Company's bylaws. No financial reporting period is covered in this document.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is limited to a legal amendment and does not contain financial statements or performance data.
Material Changes
The Board of Directors approved an amendment and restatement of the Company's bylaws effective September 3, 2026. The material change is as follows:
- Quorum Requirement Reduction: The requisite quorum for stockholder meetings to transact business has been reduced from the holders of a majority of voting power to the holders of one-third (1/3) of the voting power of capital stock issued and outstanding.
- Scope: This applies to meetings where stockholders are present in person, by remote communication, or represented by proxy, unless otherwise required by law or the Certificate of Incorporation.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The document focuses solely on the procedural amendment of the bylaws.
Investor Verification Checklist
- Verify the full text of the Amended and Restated Bylaws attached as Exhibit 3.1 to confirm the exact language of the quorum reduction.
- Confirm whether this change impacts the Company's ability to hold meetings during periods of low shareholder participation.
- Check for any related proxy statements or shareholder meeting notices that may detail the rationale for this governance change.